Advanced search
Publication Cover
Acta Oncologica Volume 55, 2016 - Issue 4
Journal homepage
1,558
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: Central Nervous System Tumors

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan

Thomas UrupDepartment of Radiation Biology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark; ;Department of Oncology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark; Correspondence[email protected]
,
Rikke Hedegaard DahlrotDepartment of Oncology, Odense University Hospital, Odense, Denmark;
,
Kirsten GrunnetDepartment of Radiation Biology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark; ;Department of Oncology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark;
,
Ib Jarle ChristensenLaboratory of Gastroenterology, University of Copenhagen, Hvidovre Hospital, Copenhagen, Denmark;
,
Signe Regner MichaelsenDepartment of Radiation Biology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark;
,
Anders ToftDepartment of Radiation Biology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark;
,
Vibeke Andrée LarsenDepartment of Radiology, Center of Diagnostic Investigation, Rigshospitalet, Copenhagen, Denmark;
,
Helle BroholmDepartment of Neuropathology, Center of Diagnostic Investigation, Rigshospitalet, Copenhagen, Denmark;
,
Michael KosteljanetzDepartment of Neurosurgery, the Neurocenter, Rigshospitalet, Copenhagen, Denmark;
,
Steinbjørn HansenDepartment of Oncology, Odense University Hospital, Odense, Denmark;
,
Hans Skovgaard PoulsenDepartment of Radiation Biology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark; ;Department of Oncology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark;
&
Ulrik LassenDepartment of Radiation Biology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark; ;Department of Oncology, the Finsen Center, Rigshospitalet, Copenhagen, Denmark; ;Phase I Unit, Finsencenter, Rigshospitalet, Copenhagen, Denmark.
 show all
Pages 418-422 | Received 22 Dec 2014, Accepted 26 Oct 2015, Published online: 01 Feb 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria Dinche Johansen, Thomas Urup, Camilla Bjørnbak Holst, Ib Jarle Christensen, Kirsten Grunnet, Ulrik Lassen, Søren Friis & Hans Skovgaard Poulsen. (2018) Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors. Cancer Investigation 36:9-10, pages 512-519.
Read now

Articles from other publishers (8)

Ishaan Ashwini Tewarie, Joeky T. Senders, Stijn Kremer, Sharmila Devi, William B. Gormley, Omar Arnaout, Timothy R. Smith & Marike L. D. Broekman. (2020) Survival prediction of glioblastoma patients—are we there yet? A systematic review of prognostic modeling for glioblastoma and its clinical potential. Neurosurgical Review 44:4, pages 2047-2057.
Crossref
Armita Armina Abedi, Kirsten Grunnet, Ib Jarle Christensen, Signe Regner Michaelsen, Aida Muhic, Søren Møller, Benedikte Hasselbalch, Hans Skovgaard Poulsen & Thomas Urup. (2021) A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution. Frontiers in Oncology 11.
Crossref
Fausto Petrelli, Agostina De Stefani, Antonio Ghidini, Lorenza Bruschieri, Valentina Riboldi, Lorenzo Dottorini, Alessandro Iaculli, Alberto Zaniboni & Francesca Trevisan. (2020) Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis. Journal of Neurology 268:2, pages 440-447.
Crossref
Thomas Urup, Linn Gillberg, Katja Kaastrup, Maya Jeje Schuang Lü, Signe Regner Michaelsen, Vibeke Andrée Larsen, Ib Jarle Christensen, Helle Broholm, Ulrik Lassen, Kirsten Grønbæk & Hans Skovgaard Poulsen. (2020) Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma. Molecular Oncology 14:5, pages 964-973.
Crossref
Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy & Albert Lai. (2019) Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series. CNS Oncology 8:2, pages CNS35.
Crossref
J. N. Jakobsen, T. Urup, K. Grunnet, A. Toft, M. D. Johansen, S. H. Poulsen, I. J. Christensen, A. Muhic & H. S. Poulsen. (2018) Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients. Journal of Neuro-Oncology 137:2, pages 439-446.
Crossref
Adrienne C. Scheck. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 87 104 .
Thomas Urup, Line Mærsk Staunstrup, Signe Regner Michaelsen, Kristoffer Vitting-Seerup, Marc Bennedbæk, Anders Toft, Lars Rønn Olsen, Lars Jønson, Shohreh Issazadeh-Navikas, Helle Broholm, Petra Hamerlik, Hans Skovgaard Poulsen & Ulrik Lassen. (2017) Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients. BMC Cancer 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.